VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
69,605
AK1,598
AL5,164
AR3,304
AS44
AZ13,065
CA56,776
CO10,768
CT7,579
DC1,607
DE1,621
FL35,168
FM3
GA13,024
GU79
HI2,138
IA4,232
ID2,415
IL18,853
IN22,332
KS4,178
KY6,673
LA4,610
MA13,557
MD11,644
ME2,929
MH8
MI17,397
MN11,026
MO8,648
MP30
MS2,605
MT2,090
NC14,970
ND1,212
NE2,651
NH2,813
NJ16,744
NM3,631
NV3,974
NY31,961
OH17,635
OK5,832
OR7,751
PA21,968
PR2,049
QM2
RI1,865
SC5,857
SD1,114
TN8,379
TX33,247
UT3,931
VA13,592
VI49
VT1,646
WA13,495
WI10,158
WV2,175
WY792
XB5
XL1
XV2

ID: 1610390
Sex: F
Age: 24
State: PA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in arm after first dose; redness; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm after first dose), ERYTHEMA (redness) and RASH (Rash) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm after first dose), ERYTHEMA (redness) and RASH (Rash). At the time of the report, PAIN IN EXTREMITY (Pain in arm after first dose), ERYTHEMA (redness) and RASH (Rash) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications were provided No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1610391
Sex: F
Age:
State: SC

Vax Date:
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: My arm is sore; fibromyalgia; It hurts from my left hip down to my left knee; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (My arm is sore), FIBROMYALGIA (fibromyalgia) and PAIN (It hurts from my left hip down to my left knee) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (My arm is sore), FIBROMYALGIA (fibromyalgia) and PAIN (It hurts from my left hip down to my left knee). At the time of the report, PAIN IN EXTREMITY (My arm is sore), FIBROMYALGIA (fibromyalgia) and PAIN (It hurts from my left hip down to my left knee) outcome was unknown. Not Provided No concomitant medication was reported. Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26-MAY-2021. No newinformation

Other Meds:

Current Illness:

ID: 1610392
Sex: F
Age: 24
State: TX

Vax Date: 03/21/2021
Onset Date: 04/21/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: warm feeling all over; Fatigue; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea). At the time of the report, FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea) outcome was unknown. No concomitants were reported. No treatment was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.

Other Meds:

Current Illness:

ID: 1610393
Sex: F
Age: 73
State: AZ

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: her arm was itching; arm is swollen and warm; her arm is warm; the injection site was red the redness progressed down her arm 4 inches long; her arm a little sore; her arm warm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm a little sore), SKIN WARM (her arm warm), PRURITUS (her arm was itching), PERIPHERAL SWELLING (arm is swollen and warm) and SKIN WARM (her arm is warm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Medical history was not reported. Concomitant products included SPIRONOLACTONE, FUROSEMIDE and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (her arm a little sore) and SKIN WARM (her arm warm). On 21-Apr-2021, the patient experienced PRURITUS (her arm was itching), PERIPHERAL SWELLING (arm is swollen and warm), SKIN WARM (her arm is warm) and VACCINATION SITE ERYTHEMA (the injection site was red the redness progressed down her arm 4 inches long). On 14-Apr-2021, PAIN IN EXTREMITY (her arm a little sore) had resolved, SKIN WARM (her arm warm) had resolved with sequelae. At the time of the report, PRURITUS (her arm was itching), PERIPHERAL SWELLING (arm is swollen and warm), SKIN WARM (her arm is warm) and VACCINATION SITE ERYTHEMA (the injection site was red the redness progressed down her arm 4 inches long) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication include Eye drop for glaucoma. Treatment included Cortisone cream.

Other Meds: SPIRONOLACTONE; FUROSEMIDE; CRESTOR

Current Illness:

ID: 1610394
Sex: M
Age: 57
State: MI

Vax Date: 03/08/2021
Onset Date: 03/28/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: It is been more than 35 days and did not get second dose; Covid-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It is been more than 35 days and did not get second dose) and SARS-COV-2 TEST POSITIVE (Covid-19 virus test positive) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Covid-19 virus test positive). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It is been more than 35 days and did not get second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It is been more than 35 days and did not get second dose) and SARS-COV-2 TEST POSITIVE (Covid-19 virus test positive) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1610395
Sex: M
Age: 17
State: TX

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 17 year-old received 1st dose Moderna COVID-19 vaccine; denied to give 2nd dose since patient is 17 years old; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old received 1st dose Moderna COVID-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (denied to give 2nd dose since patient is 17 years old) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old received 1st dose Moderna COVID-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (denied to give 2nd dose since patient is 17 years old). On 25-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old received 1st dose Moderna COVID-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (denied to give 2nd dose since patient is 17 years old) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided No treatment medications were provided

Other Meds:

Current Illness:

ID: 1610396
Sex: F
Age:
State: AZ

Vax Date: 03/21/2021
Onset Date: 04/20/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of AGITATION (feeling agitated) and EMOTIONAL DISORDER (very emotional) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 045A21A) for COVID-19 vaccination. No medical history was provided by the reporter. On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced AGITATION (feeling agitated). On 21-Apr-2021, the patient experienced EMOTIONAL DISORDER (very emotional). At the time of the report, AGITATION (feeling agitated) and EMOTIONAL DISORDER (very emotional) outcome was unknown. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No laboratory details were provided. No treatment medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1610397
Sex: M
Age:
State: NJ

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain on both quadriceps; leg pain/ pain in arm; muscle on fire; tenderness at vaccination site; burning sensation; stiffness in his R quadricep; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation), MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep), PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm) and MYALGIA (muscle on fire) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported by the reporter. Concomitant products included BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) for an unknown indication. On 21-Apr-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced FATIGUE (fatigue). On 22-Apr-2021, the patient experienced BURNING SENSATION (burning sensation) and MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep). On an unknown date, the patient experienced PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm), MYALGIA (muscle on fire) and VACCINATION SITE PAIN (tenderness at vaccination site). At the time of the report, BURNING SENSATION (burning sensation), MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep), PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm), MYALGIA (muscle on fire), VACCINATION SITE PAIN (tenderness at vaccination site) and FATIGUE (fatigue) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included occasionally nausea medications. Event outcome details were not reported. Patient wants to know whether these side effects normal? and what should he do for the muscle aches?

Other Meds: PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]

Current Illness:

ID: 1610398
Sex: F
Age: 52
State: NJ

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tingling in her throat; "funny sensation" in throat; woozy; pain in back; pain in lung when breathing; pain in lung when breathing; body inflammation on CAT scan; sore arm/body ache; headache; Her arm was also sore at the site of the injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back) and PULMONARY PAIN (pain in lung when breathing) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in November 2020. Concomitant products included NORETHINDRONE ACETATE, MULTI VITAMINS & MINERALS and PRO BIOTIC BLEND for an unknown indication. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back), PULMONARY PAIN (pain in lung when breathing), DYSPNOEA (pain in lung when breathing), INFLAMMATION (body inflammation on CAT scan), MYALGIA (sore arm/body ache), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm was also sore at the site of the injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Inflammation, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Inflammation, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Inflammation, at an unspecified dose and frequency. At the time of the report, PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back), PULMONARY PAIN (pain in lung when breathing), DYSPNOEA (pain in lung when breathing), INFLAMMATION (body inflammation on CAT scan), MYALGIA (sore arm/body ache), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm was also sore at the site of the injection) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: elevated (High) Test for blood clot was elevated. On an unknown date, Computerised tomogram: inflammation (abnormal) Inflammation all over the body. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On an unknown date, prior to mRNA-1273, antibody test was positive. This case was linked to US-MODERNATX, INC.-MOD-2021-085271 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-085271:Case for husband

Other Meds: NORETHINDRONE ACETATE; MULTI VITAMINS & MINERALS; PRO BIOTIC BLEND

Current Illness:

ID: 1610399
Sex: F
Age: 57
State: TN

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: throbbing pain; started having pain in the right arm; arm started swelling; sore; swelled around the injection site; hurt from all the way down from shoulder to elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (throbbing pain), PAIN IN EXTREMITY (started having pain in the right arm), PERIPHERAL SWELLING (arm started swelling), PAIN (sore) and INJECTION SITE SWELLING (swelled around the injection site) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (throbbing pain), PAIN IN EXTREMITY (started having pain in the right arm), PERIPHERAL SWELLING (arm started swelling), PAIN (sore), INJECTION SITE SWELLING (swelled around the injection site) and ARTHRALGIA (hurt from all the way down from shoulder to elbow). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, PAIN (throbbing pain), PAIN IN EXTREMITY (started having pain in the right arm), PERIPHERAL SWELLING (arm started swelling), PAIN (sore) and INJECTION SITE SWELLING (swelled around the injection site) had not resolved and ARTHRALGIA (hurt from all the way down from shoulder to elbow) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up was received and event outcome was updated to recovered/resolved.

Other Meds:

Current Illness:

ID: 1610400
Sex: M
Age: 67
State: VA

Vax Date: 04/12/2021
Onset Date: 04/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red rash on left breast like a hatch of 2 square inches; Rash is raised; Rash has white little pustules coming out across it; A little fatigue; Slight headache; Shingles; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised), RASH PUSTULAR (Rash has white little pustules coming out across it), HERPES ZOSTER (Shingles) and FATIGUE (A little fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Sore back. Concomitant products included IBUPROFEN for Sore back. On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced FATIGUE (A little fatigue) and HEADACHE (Slight headache). In April 2021, the patient experienced HERPES ZOSTER (Shingles). On 19-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised) and RASH PUSTULAR (Rash has white little pustules coming out across it). The patient was treated with HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. In May 2021, HERPES ZOSTER (Shingles) had resolved. At the time of the report, RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised), RASH PUSTULAR (Rash has white little pustules coming out across it), FATIGUE (A little fatigue) and HEADACHE (Slight headache) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. This case was linked to MOD-2021-176879 (second dose case) (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received contain significant information added new event shingles and updated outcome of all the reported events from unknown to recovered.

Other Meds: IBUPROFEN

Current Illness: Sore back

ID: 1610401
Sex: M
Age: 29
State: OK

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bad ringing in the ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Bad ringing in the ears) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced TINNITUS (Bad ringing in the ears). At the time of the report, TINNITUS (Bad ringing in the ears) had not resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. On 30-Apr-2021, The patient's father reported that the patient experienced ringing of ear a day or two later after the 2nd shot and was better after 2-3 days, but on 29-Apr-2021 "the ringing of ear" had bothered him again and he wished he didn't receive the vaccine. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1610402
Sex: M
Age:
State: NC

Vax Date: 03/22/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037821B) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment information was not provided.

Other Meds:

Current Illness: Hypertension

ID: 1610403
Sex: F
Age:
State: IL

Vax Date: 03/25/2021
Onset Date: 03/28/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rapid HR; Extreme body ache; Chills; Extreme fatigue; 103F fever for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid HR), PAIN (Extreme body ache), CHILLS (Chills), FATIGUE (Extreme fatigue) and PYREXIA (103F fever for 2 days) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced HEART RATE INCREASED (Rapid HR), PAIN (Extreme body ache), CHILLS (Chills), FATIGUE (Extreme fatigue) and PYREXIA (103F fever for 2 days). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form and IBUPROFEN (MOTRIN IB) at a dose of 1 dosage form. At the time of the report, HEART RATE INCREASED (Rapid HR), PAIN (Extreme body ache), CHILLS (Chills), FATIGUE (Extreme fatigue) and PYREXIA (103F fever for 2 days) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1610404
Sex: F
Age:
State: FL

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine; feels like her forehead is hot but doesn't have a fever; ear was red and itrritated; ear got sore pain radiated down her neck; pain radiated down her neck; piece outside of her ear swelled up; tiny bit of a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (tiny bit of a sore arm), EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck), EAR SWELLING (piece outside of her ear swelled up) and ERYTHEMA (ear was red and itrritated) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Penicillin allergy. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (tiny bit of a sore arm). On 19-Mar-2021, the patient experienced EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck) and EAR SWELLING (piece outside of her ear swelled up). On 16-Apr-2021, the patient experienced ERYTHEMA (ear was red and itrritated). On 22-Apr-2021, the patient experienced FEELING HOT (feels like her forehead is hot but doesn't have a fever). On an unknown date, the patient experienced HYPOACUSIS (still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 23-Mar-2021, PAIN IN EXTREMITY (tiny bit of a sore arm), EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck) and EAR SWELLING (piece outside of her ear swelled up) had resolved. At the time of the report, ERYTHEMA (ear was red and itrritated), FEELING HOT (feels like her forehead is hot but doesn't have a fever) and HYPOACUSIS (still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 99 (High) High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided by the reporter. On 16 Apr 2021, the patient went to her doctor.Treatment for the events included unspecified ear drops. This case was linked to MOD-2021-276330, MOD-2021-276330 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received and contained significant information updated new event she cannot hear well as she could prior to the 1st vaccine.

Other Meds:

Current Illness: Penicillin allergy

ID: 1610405
Sex: F
Age:
State: MN

Vax Date: 04/15/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chest pain off and on; headaches are getting worse; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain off and on) and HEADACHE (headaches are getting worse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain off and on) and HEADACHE (headaches are getting worse). At the time of the report, CHEST PAIN (chest pain off and on) and HEADACHE (headaches are getting worse) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details not provided. Concomitant details not provided.

Other Meds:

Current Illness:

ID: 1610406
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication reported. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2021-085474, US-MODERNATX, INC.-MOD-2021-085474 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up was received on 27-MAY-2021. Patient stated that they gave all information over phone and the form was confusing. It contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-085474:case for husband US-MODERNATX, INC.-MOD-2021-085474:case for wife

Other Meds:

Current Illness:

ID: 1610407
Sex: F
Age: 74
State: TX

Vax Date: 03/23/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dose leaked out of connection between syringe and needle; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Dose leaked out of connection between syringe and needle) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concurrent medical conditions included Allergic reaction to drug, Allergic reaction to drug and Blood pressure. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced UNDERDOSE (Dose leaked out of connection between syringe and needle). On 22-Apr-2021, UNDERDOSE (Dose leaked out of connection between syringe and needle) had resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable. No treatment medication information was provided.

Other Meds:

Current Illness: Allergic reaction to drug; Blood pressure

ID: 1610408
Sex: F
Age:
State: SC

Vax Date: 03/25/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: been having some headaches off and on that she is not used to having; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (been having some headaches off and on that she is not used to having) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. Concomitant products included LEVOTHYROXINE and ROSUVASTATIN for an unknown indication. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (been having some headaches off and on that she is not used to having). At the time of the report, HEADACHE (been having some headaches off and on that she is not used to having) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information provided.

Other Meds: LEVOTHYROXINE; ROSUVASTATIN

Current Illness:

ID: 1610409
Sex: M
Age: 51
State: FL

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feeling of warmth; headache; myalgia; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (feeling of warmth), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included METFORMIN for Diabetes. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced FEELING HOT (feeling of warmth), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills). At the time of the report, FEELING HOT (feeling of warmth), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient was receiving blood pressure medication as concomitant medication.

Other Meds: METFORMIN

Current Illness: Diabetes; Hypertension

ID: 1610410
Sex: M
Age:
State: TX

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: son is 16 and just got the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose). On 31-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1610411
Sex: U
Age:
State: CA

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: First dose given at 17 years of age; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given at 17 years of age) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given at 17 years of age). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given at 17 years of age) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1610412
Sex: F
Age:
State:

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; swelling under eyes after the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and EYE SWELLING (swelling under eyes after the vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced HEADACHE (headache) and EYE SWELLING (swelling under eyes after the vaccination). At the time of the report, HEADACHE (headache) and EYE SWELLING (swelling under eyes after the vaccination) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1610413
Sex: M
Age: 34
State: MI

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Half dose Administered; needle of syringe was defective and broken; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Half dose Administered) and NEEDLE ISSUE (needle of syringe was defective and broken) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced UNDERDOSE (Half dose Administered) and NEEDLE ISSUE (needle of syringe was defective and broken). On 22-Apr-2021, UNDERDOSE (Half dose Administered) and NEEDLE ISSUE (needle of syringe was defective and broken) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered UNDERDOSE (Half dose Administered) and NEEDLE ISSUE (needle of syringe was defective and broken) to be not applicable. Concomitant and treatment information not provided.

Other Meds:

Current Illness:

ID: 1610414
Sex: F
Age: 31
State:

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Just received the 1st dose and stated that she is pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Just received the 1st dose and stated that she is pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 29-Oct-2020 and the estimated date of delivery was 11-Aug-2021. On 22-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Just received the 1st dose and stated that she is pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twenty-fifth week of the pregnancy. On 22-Apr-2021, EXPOSURE DURING PREGNANCY (Just received the 1st dose and stated that she is pregnant) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1610415
Sex: F
Age: 58
State: KY

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching all over; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The patient's past medical history included Hives (Hives/urticaria). Concurrent medical conditions included Hypertension (Hypertension (Essential)) since January 2017, Drug allergy (Fluticasone caused nasal swelling and sores in nose.), Food allergy (beef, rice (itching)) since 2006, Allergy to molds and Insect bite allergy (dust mites). Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) for Allergy, LISINOPRIL for Hypertension. On 25-Mar-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PRURITUS (Itching all over). On 25-Mar-2021, PRURITUS (Itching all over) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment: allergy medication Symptom text: Patient stated that within 10 minutes of receiving first dose her nose and scalp began mildly itching which spread to forehead, face and skin throughout the day. Face felt prickly. Itching lasted until the last dose of Xyzal (resolved within 10-15 minutes of Xyzal). Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Patient demographics, medical history, concomitant medication, vaccination facility details added. Reporter information, dose details updated.

Other Meds: LISINOPRIL; XYZAL

Current Illness: Allergy to molds; Drug allergy (Fluticasone caused nasal swelling and sores in nose.); Food allergy (beef, rice (itching)); Hypertension (Hypertension (Essential)); Insect bite allergy (dust mites)

ID: 1610416
Sex: U
Age: 53
State: MN

Vax Date: 03/24/2021
Onset Date: 04/18/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore throat; cough; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and COUGH (cough) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 001C21A) for COVID-19 vaccination. No medical history was reported. The patient's past medical history included No adverse event (no medical history reported). Concomitant products included METHOTREXATE, FOLIC ACID, CALCIUM, MULTIVITAMIN [VITAMINS NOS] and VITAMIN D3 for an unknown indication. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 18-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and COUGH (cough). At the time of the report, OROPHARYNGEAL PAIN (sore throat) and COUGH (cough) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, COVID-19: (Positive) positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-085691.

Other Meds: METHOTREXATE; FOLIC ACID; CALCIUM; MULTIVITAMIN [VITAMINS NOS]; VITAMIN D3

Current Illness:

ID: 1610417
Sex: F
Age: 73
State: NM

Vax Date: 03/12/2021
Onset Date: 04/11/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy rash left arm; Warm to the touch rash left arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash left arm) and FEELING HOT (Warm to the touch rash left arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A/026B21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced RASH PRURITIC (Itchy rash left arm) and FEELING HOT (Warm to the touch rash left arm). At the time of the report, RASH PRURITIC (Itchy rash left arm) and FEELING HOT (Warm to the touch rash left arm) outcome was unknown. Unknown No concomitant medications provided. Treatment included Calamine lotion and cortisone cream Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Non-Significant follow up appended

Other Meds:

Current Illness:

ID: 1610418
Sex: M
Age: 68
State: TN

Vax Date: 03/02/2021
Onset Date: 03/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (felt pain pain in right hip down his legs like sciatic nerve), MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches), PYREXIA (pyrexia), HEADACHE (headache) and FATIGUE (fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 027b21a04) for COVID-19 vaccination. No medical history was provided by the reporter. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PYREXIA (pyrexia). On 09-Apr-2021, the patient experienced HEADACHE (headache) and FATIGUE (fatigue). On an unknown date, the patient experienced PAIN (felt pain pain in right hip down his legs like sciatic nerve) and MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches). The patient was treated with IBUPROFEN at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (felt pain pain in right hip down his legs like sciatic nerve), MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches), PYREXIA (pyrexia), HEADACHE (headache) and FATIGUE (fatigue) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.5 99.5. On an unknown date, Multiple sclerosis: Inconclusive. On an unknown date, Rheumatoid arthritis: Inconclusive. On an unknown date, X-ray: narrowing in right hip 2mm left hip 4mm. No concomitant medication included. Treatment medications included steroids for inflammation were provided. This case was linked to MOD-2021-085735. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: significant follow up received, patient demographics updated, AE progress/outcome, Lab work, Dose 1 and dose 2 information updated.

Other Meds:

Current Illness:

ID: 1610419
Sex: F
Age: 70
State: CT

Vax Date: 03/23/2021
Onset Date: 04/16/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: allergy on the forehead, on the left side and in both eyes; allergy on the forehead, on the left side and in both eyes; This spontaneous case was reported by a physician and describes the occurrence of EYE ALLERGY (allergy on the forehead, on the left side and in both eyes) and HYPERSENSITIVITY (allergy on the forehead, on the left side and in both eyes) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. No medical history was reported. Concomitant products included LOSARTAN POTASSIUM, CLONIDINE HCL, HYDROXYZINE, CARBINOXAMINE MALEATE (OMEGA 100), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN, PENTOXIFYLLINE, CHOLECALCIFEROL, ESCITALOPRAM, CLONAZEPAM, HYDROCHLOROTHIAZIDE (HYDRODIURIL), DICYCLOVERINE HYDROCHLORIDE (BENTYL), PANTOPRAZOLE, CEFIXIME (FLEXERIL [CEFIXIME]) and COLECALCIFEROL (VITAMIN D 3) for an unknown indication. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced EYE ALLERGY (allergy on the forehead, on the left side and in both eyes) and HYPERSENSITIVITY (allergy on the forehead, on the left side and in both eyes). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, EYE ALLERGY (allergy on the forehead, on the left side and in both eyes) and HYPERSENSITIVITY (allergy on the forehead, on the left side and in both eyes) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds: LOSARTAN POTASSIUM; CLONIDINE HCL; HYDROXYZINE; OMEGA 100; ASPIRIN (E.C.); ATORVASTATIN; PENTOXIFYLLINE; CHOLECALCIFEROL; ESCITALOPRAM; CLONAZEPAM; HYDRODIURIL; BENTYL; PANTOPRAZOLE; FLEXERIL [CEFIXIME]; VITAMIN D 3

Current Illness:

ID: 1610420
Sex: M
Age:
State: NM

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: left arm and leg felt tired; arm bleed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (arm bleed) and MUSCULAR WEAKNESS (left arm and leg felt tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No medical history was provided by reporter. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (arm bleed). On 20-Apr-2021, the patient experienced MUSCULAR WEAKNESS (left arm and leg felt tired). On 08-Apr-2021, VACCINATION SITE HAEMORRHAGE (arm bleed) outcome was unknown. On 20-Apr-2021, MUSCULAR WEAKNESS (left arm and leg felt tired) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No information provided about any concomitant and treatment medications.

Other Meds:

Current Illness:

ID: 1610421
Sex: F
Age:
State: SC

Vax Date: 03/26/2021
Onset Date: 04/09/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: big rash (rash around the injection site); soreness where she received the vaccination on her right shoulder; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH and VACCINATION SITE PAIN (soreness where she received the vaccination on her right shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced INJECTION SITE RASH (rash around the injection site) and VACCINATION SITE PAIN (soreness where she received the vaccination on her right shoulder). The patient was treated with Manual therapy of applied alcohol for Injection site rash. On 10-Apr-2021, INJECTION SITE RASH (rash around the injection site) and VACCINATION SITE PAIN (soreness where she received the vaccination on her right shoulder) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Treatment medications were not provided by the reporter. Most recent FOLLOW-UP information incorporated above included, On 06-Jul-2021: No significant information was received.

Other Meds:

Current Illness:

ID: 1610422
Sex: F
Age: 36
State: TN

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a nurse, describes the occurrence of mouth ulcers, face swelling (swollen, puffy face), dizziness, pyrexia (intermittent fevers) and chills in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Apr 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 9, 2021, patient experienced dizziness, pyrexia (intermittent fevers), chills, nausea and fatigue. On Apr 14, 2021, patient experienced face swelling (swollen, puffy face) and lymphadenopathy (swollen lymph nodes). On Apr 18, 2021, patient had a generalized rash. On Apr 21, 2021, patient experienced mouth ulcers. On Apr 22, 2021, patient experienced vomiting. At the time of the report, mouth ulcers, face swelling (swollen, puffy face), dizziness, pyrexia (intermittent fevers), chills, nausea, fatigue, lymphadenopathy (swollen lymph nodes), generalized rash and vomiting outcome: unknown. The reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1610423
Sex: F
Age: 29
State: TX

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 21, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 22, 2021, patient experienced pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea. At the time of the report, pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea outcome: unknown. Action taken with mRNA-1273 in response to the event: not applicable. Treatment information not reported.

Other Meds:

Current Illness:

ID: 1610424
Sex: F
Age: 38
State: NC

Vax Date: 02/04/2021
Onset Date: 03/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Face tingling; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Face tingling) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (Face tingling). At the time of the report, PARAESTHESIA (Face tingling) outcome was unknown. Not Provided No concomitant medications were reported. No treatment information was provided. The patient also had other symptom which she could not explain.

Other Meds:

Current Illness:

ID: 1610425
Sex: F
Age:
State: MI

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: splitting headache; sore muscles; ran a temperature of 99.9 F for half a day or better; tenderness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness in the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced TENDERNESS (tenderness in the arm). Not Provided No concomitant details were provided Treatment details include Tylenol The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. (E2B Linked Report).; Sender's Comments: :2nd dose :wife case for dose 1 :wife case for dose 1

Other Meds:

Current Illness:

ID: 1610426
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very sick the first day he got the shot; The nurse at the store in spilled it on his arm.; The nurse at the store in spilled it on his arm.; Fever; Headache; Felt very achy on the left arm; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the store in spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the store in spilled it on his arm.), PYREXIA (Fever) and HEADACHE (Headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was not provided by reporter. Concomitant products included VITAMIN C [ASCORBIC ACID], ERGOCALCIFEROL, RETINOL (VITAMIN A + D) and ZINC for an unknown indication. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the store in spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the store in spilled it on his arm.), PYREXIA (Fever), HEADACHE (Headache) and VACCINATION SITE PAIN (Felt very achy on the left arm). At the time of the report, ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the store in spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the store in spilled it on his arm.), PYREXIA (Fever), HEADACHE (Headache) and VACCINATION SITE PAIN (Felt very achy on the left arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable Treatment information was not provided Most recent FOLLOW-UP information incorporated above includes: On 23-May-2021: Outcome of events changed from unknown to recovered, new events such as device connection issue and under-dose were added.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN A + D; ZINC

Current Illness:

ID: 1610427
Sex: F
Age: 78
State: IL

Vax Date: 04/19/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I get urinary tract infections, & I feel like I'm getting one; Injection site is little red, where you can tell that a needle went in; A little tired; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (I get urinary tract infections, & I feel like I'm getting one), VACCINATION SITE ERYTHEMA (Injection site is little red, where you can tell that a needle went in) and FATIGUE (A little tired) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The patient's past medical history included UTI. On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced URINARY TRACT INFECTION (I get urinary tract infections, & I feel like I'm getting one), VACCINATION SITE ERYTHEMA (Injection site is little red, where you can tell that a needle went in) and FATIGUE (A little tired). At the time of the report, URINARY TRACT INFECTION (I get urinary tract infections, & I feel like I'm getting one), VACCINATION SITE ERYTHEMA (Injection site is little red, where you can tell that a needle went in) and FATIGUE (A little tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment information was reported.

Other Meds:

Current Illness:

ID: 1610428
Sex: F
Age: 43
State: CT

Vax Date: 03/17/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizzy; feel hot like crazy; chills; Bad headache; Nausea; Fever 100F; Felt like throwing up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache) and NAUSEA (Nausea) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache), NAUSEA (Nausea), PYREXIA (Fever 100F) and VOMITING (Felt like throwing up). At the time of the report, DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache), NAUSEA (Nausea), PYREXIA (Fever 100F) and VOMITING (Felt like throwing up) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. No Relevant concomitant medications was reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1610429
Sex: M
Age: 69
State: PA

Vax Date: 03/24/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red blotchy rash all over his back; Pretty bad skin rash mostly on my back and little bit on my chest; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red blotchy rash all over his back) and RASH (Pretty bad skin rash mostly on my back and little bit on my chest) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 007B21A) for COVID-19 vaccination. The patient's past medical history included Lichen planus. Concurrent medical conditions included Neuropathy. Concomitant products included PREGABALIN (LYRICA) and GABAPENTIN for Neuropathy. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced ERYTHEMA (Red blotchy rash all over his back) and RASH (Pretty bad skin rash mostly on my back and little bit on my chest). At the time of the report, ERYTHEMA (Red blotchy rash all over his back) and RASH (Pretty bad skin rash mostly on my back and little bit on my chest) outcome was unknown. Not Provided Action taken with mRNA-1273 in response to the events was not Applicable. Treatment information included skin cream. This case was linked to MOD-2021-085633 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Additional information received on 26-05-2021 included second dose batch number, concomitant medications, treatment medication and additional event was updated. On 20-Jul-2021: Follow up received on 20-JUL-2021 contains no significant information.

Other Meds: LYRICA; GABAPENTIN

Current Illness: Neuropathy

ID: 1610430
Sex: F
Age: 24
State: ID

Vax Date: 04/09/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hurts to lift her arm; hot to the touch/warm; possibly was an allergic reaction to the vaccine; itchy; arm was swollen; rashy / really big rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE SWELLING (arm was swollen) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE RASH (rashy / really big rash). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE RASH (rashy / really big rash) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Relevant concomitant product usage were not reported by the reporter. No treatment details were added. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up Information includes Patient Demographics, 2 nd dose Information and Events Outcome

Other Meds:

Current Illness:

ID: 1610431
Sex: F
Age:
State: MI

Vax Date: 03/23/2021
Onset Date: 04/20/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: splitting headache; sore muscles; ran a temperature of 99.9 F for half a day or better; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (splitting headache), MYALGIA (sore muscles) and PYREXIA (ran a temperature of 99.9 F for half a day or better) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (splitting headache), MYALGIA (sore muscles) and PYREXIA (ran a temperature of 99.9 F for half a day or better). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Apr-2021, PYREXIA (ran a temperature of 99.9 F for half a day or better) had resolved. At the time of the report, HEADACHE (splitting headache) and MYALGIA (sore muscles) outcome was unknown. Concomitant drugs were not reported. This case was linked to US-MODERNATX, INC.-MOD-2021-085661, US-MODERNATX, INC.-MOD-2021-086386, US-MODERNATX, INC.-MOD-2021-086668 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-085661: US-MODERNATX, INC.-MOD-2021-086668:wife case for 1 dose US-MODERNATX, INC.-MOD-2021-086386:father dose 2

Other Meds:

Current Illness:

ID: 1610432
Sex: M
Age: 61
State: GA

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: in bed for two days so he lost two days from work; diarrhea; 103 fever / still has the low grade fever for the past two weeks; blurry vision; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (in bed for two days so he lost two days from work), DIARRHOEA (diarrhea), VISION BLURRED (blurry vision) and PYREXIA (103 fever / still has the low grade fever for the past two weeks) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026AZ1A) for COVID-19 vaccination. No Medical History information was reported. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VISION BLURRED (blurry vision). On 09-Apr-2021, the patient experienced BEDRIDDEN (in bed for two days so he lost two days from work), DIARRHOEA (diarrhea) and PYREXIA (103 fever / still has the low grade fever for the past two weeks). On 09-Apr-2021, VISION BLURRED (blurry vision) had resolved. At the time of the report, BEDRIDDEN (in bed for two days so he lost two days from work) outcome was unknown and DIARRHOEA (diarrhea) and PYREXIA (103 fever / still has the low grade fever for the past two weeks) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, Body temperature: 103 High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Significant follow up updated medication Clyndomycin and Second dose added

Other Meds:

Current Illness:

ID: 1610433
Sex: F
Age: 59
State: TX

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: jitterness; headache; nausea; slept all day and night; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (slept all day and night), NERVOUSNESS (jitterness), HEADACHE (headache) and NAUSEA (nausea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. Concurrent medical conditions included COPD. On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Apr-2021, the patient experienced HYPERSOMNIA (slept all day and night), HEADACHE (headache) and NAUSEA (nausea). On 22-Apr-2021, the patient experienced NERVOUSNESS (jitterness). At the time of the report, PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (slept all day and night), NERVOUSNESS (jitterness), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. Treatment medication was not provided. concomitant product was not provided Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow-up information received on 02-JUN-2021 contains non-significant information.

Other Meds:

Current Illness: COPD

ID: 1610434
Sex: M
Age: 67
State: KY

Vax Date: 04/16/2021
Onset Date: 04/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: soreness at the injection site; joint pain; nauseousness; headache; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), ARTHRALGIA (joint pain), MYALGIA (muscle pain), NAUSEA (nauseousness) and INJECTION SITE PAIN (soreness at the injection site) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced HEADACHE (headache) and MYALGIA (muscle pain). On 22-Apr-2021, the patient experienced ARTHRALGIA (joint pain) and NAUSEA (nauseousness). On an unknown date, the patient experienced INJECTION SITE PAIN (soreness at the injection site). At the time of the report, HEADACHE (headache), ARTHRALGIA (joint pain), MYALGIA (muscle pain), NAUSEA (nauseousness) and INJECTION SITE PAIN (soreness at the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1610435
Sex: M
Age: 62
State: NY

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine leaked upon administration; Vaccine leaked upon administration; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Vaccine leaked upon administration) and DEVICE CONNECTION ISSUE (Vaccine leaked upon administration) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced UNDERDOSE (Vaccine leaked upon administration) and DEVICE CONNECTION ISSUE (Vaccine leaked upon administration). At the time of the report, UNDERDOSE (Vaccine leaked upon administration) and DEVICE CONNECTION ISSUE (Vaccine leaked upon administration) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient reported a potential cause as a syrinx in the follow up document. No concomitant product was provided by the reporter. No treatment medications was provided by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2021-086536 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Patient's ethnic group ,race , patient route of administration and expiration date of the suspect drug has been updated .Date of birth/age at vaccination has been amended from the Follow up document.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-086536:Crosllinked case

Other Meds:

Current Illness:

ID: 1610436
Sex: F
Age:
State: MO

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Developed staph infection; 3 Quarter size red circles opposite arm of shot; itching like crazy; Hives; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Apr-2021 and was forwarded to Moderna on 22-Apr-2021. This spontaneous case was reported by a consumer and describes the occurrence of STAPHYLOCOCCAL INFECTION (Developed staph infection), RASH ERYTHEMATOUS (3 Quarter size red circles opposite arm of shot), PRURITUS (itching like crazy) and URTICARIA (Hives) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced STAPHYLOCOCCAL INFECTION (Developed staph infection), RASH ERYTHEMATOUS (3 Quarter size red circles opposite arm of shot), PRURITUS (itching like crazy) and URTICARIA (Hives). At the time of the report, STAPHYLOCOCCAL INFECTION (Developed staph infection), RASH ERYTHEMATOUS (3 Quarter size red circles opposite arm of shot), PRURITUS (itching like crazy) and URTICARIA (Hives) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. This case was linked to MOD-2021-085731 (Patient Link).; Sender's Comments: based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1610437
Sex: F
Age: 55
State: NJ

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitations), PAIN IN EXTREMITY (Left arm soreness), PERIPHERAL SWELLING (Left arm swelling), DYSPNOEA (difficulty breathing) and RASH (red rash on left side) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Stroke and Rotator cuff repair. Concurrent medical conditions included Allergy NOS and Asthma. Concomitant products included SALBUTAMOL SULFATE (VENTOLIN HFA) for an unknown indication. On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PALPITATIONS (heart palpitations), PAIN IN EXTREMITY (Left arm soreness), PERIPHERAL SWELLING (Left arm swelling), DYSPNOEA (difficulty breathing), RASH (red rash on left side) and HEADACHE (headache). On 21-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like" symptoms), WHEEZING (wheezing), ASTHMA (worsening asthma symptoms), DYSPNOEA (worsening difficulty breathing described as "almost choking"), NASOPHARYNGITIS (Cold), FEELING HOT (Really hot), PAIN (Achy), PERIPHERAL SWELLING (Arm swelling), ERYTHEMA (Arm really red whole body red), HYPERHIDROSIS (Sweaty), HYPERHIDROSIS (Hot and cold sweats), NAUSEA (Nausea), FATIGUE (Tiredness) and FATIGUE (Exhausted). On 22-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on chest), RASH ERYTHEMATOUS (Red rash on shoulder), NECK PAIN (Neck pain) and MUSCLE SPASMS (Cramping in left leg). On 29-Apr-2021, the patient experienced DYSPNOEA (My breathing is still not good), INSOMNIA (I can't sleep great), MUSCLE SPASMS (have very bad cramps in my arm and legs. I could hardly walk on my left leg) and PALPITATIONS (I am scared because of the chest palpitations). At the time of the report, PALPITATIONS (heart palpitations), PAIN IN EXTREMITY (Left arm soreness), PERIPHERAL SWELLING (Left arm swelling), DYSPNOEA (difficulty breathing), RASH (red rash on left side), INFLUENZA LIKE ILLNESS (Flu-like" symptoms), WHEEZING (wheezing), ASTHMA (worsening asthma symptoms), DYSPNOEA (worsening difficulty breathing described as "almost choking"), RASH ERYTHEMATOUS (Red rash on chest), RASH ERYTHEMATOUS (Red rash on shoulder), NECK PAIN (Neck pain), MUSCLE SPASMS (Cramping in left leg), NASOPHARYNGITIS (Cold), FEELING HOT (Really hot), PAIN (Achy), PERIPHERAL SWELLING (Arm swelling), ERYTHEMA (Arm really red whole body red), HYPERHIDROSIS (Sweaty), INSOMNIA (I can't sleep great), HYPERHIDROSIS (Hot and cold sweats), NAUSEA (Nausea), FATIGUE (Tiredness), FATIGUE (Exhausted) and HEADACHE (headache) outcome was unknown and DYSPNOEA (My breathing is still not good), MUSCLE SPASMS (have very bad cramps in my arm and legs. I could hardly walk on my left leg) and PALPITATIONS (I am scared because of the chest palpitations) had not resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included Advil, Benadryl, Ventolin HFA. Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Events updated. On 30-Apr-2021: Event Updated.

Other Meds: VENTOLIN HFA

Current Illness: Allergy NOS; Asthma

ID: 1610438
Sex: U
Age: 53
State: MN

Vax Date: 03/24/2021
Onset Date: 04/21/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for Covid-19 infection; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 001C21A) for COVID-19 vaccination. No medical history was not provided by reporter. Concomitant products included METHOTREXATE, FOLIC ACID, calcium, MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE], CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), cranbberry pills and MILK THISTLE [SILYBUM MARIANUM] for an unknown indication. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, SARS-CoV-2 test positive: (Positive) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-085639 (Patient Link).

Other Meds: METHOTREXATE; FOLIC ACID; calcium; MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYR; VITAMIN D 2000; cranbberry pills; MILK THISTLE [SILYBUM MARIANUM]

Current Illness:

ID: 1610439
Sex: F
Age: 67
State: MD

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tingling at the bottom of two toes on my left foot; stinging in my face; itchiness in my face; rash; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011A21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash). The patient was treated with PREDNISONE at a dose of UNK dosage form. At the time of the report, PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Other treatment medication included hydrocortisone cream Action taken with mRNA-1273 in response to the event was not applicable

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 584,293

Page last modified: 03 October 2021 5:28pm